Lataa...
Herpes zoster vaccine in Korea
Herpes zoster and post-herpetic neuralgia deteriorate the quality of life because of severe pain and complications, and cause considerable social and economic burden of disease. In 2012, herpes zoster vaccine was released in Korea. The efficacy of herpes zoster vaccine is known to be 51.3-66.5% amon...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
The Korean Vaccine Society
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3710929/ https://ncbi.nlm.nih.gov/pubmed/23858399 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7774/cevr.2013.2.2.92 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|